Home > Compound List > Compound details
24243-97-8 molecular structure
click picture or here to close

2-[5-methyl-2-(propan-2-yl)phenoxymethyl]-4,5-dihydro-1H-imidazole

ChemBase ID: 6403
Molecular Formular: C14H20N2O
Molecular Mass: 232.3214
Monoisotopic Mass: 232.15756327
SMILES and InChIs

SMILES:
O(c1c(C(C)C)ccc(c1)C)CC1=NCCN1
Canonical SMILES:
Cc1ccc(c(c1)OCC1=NCCN1)C(C)C
InChI:
InChI=1S/C14H20N2O/c1-10(2)12-5-4-11(3)8-13(12)17-9-14-15-6-7-16-14/h4-5,8,10H,6-7,9H2,1-3H3,(H,15,16)
InChIKey:
QRORCRWSRPKEHR-UHFFFAOYSA-N

Cite this record

CBID:6403 http://www.chembase.cn/molecule-6403.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
2-[5-methyl-2-(propan-2-yl)phenoxymethyl]-4,5-dihydro-1H-imidazole
IUPAC Traditional name
tymazoline
Brand Name
Thymazen
Synonyms
Pernazene
Tymazoline
CAS Number
24243-97-8
PubChem SID
160969710
PubChem CID
34154

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID
DrugBank DB08803 external link
PubChem 34154 external link
Data Source Data ID Price

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
H Acceptors 3  H Donor 1 
LogD (pH = 5.5) 0.6744437  LogD (pH = 7.4) 2.198444 
Log P 2.6446345  Molar Refractivity 69.5415 cm3
Polarizability 26.71834 Å3 Polar Surface Area 33.62 Å2
Rotatable Bonds 4  Lipinski's Rule of Five true 
Log P 3.2  LOG S -3.29 
Solubility (Water) 1.18e-01 g/l 

PROPERTIES

PROPERTIES

Bioassay(PubChem)

DETAILS

DETAILS

DrugBank DrugBank
DrugBank - DB08803 external link
Item Information
Drug Groups approved
Description Tymazoline is a nasal preparation.
Indication For the treatment of Inflammation of the lining of the nose and paranasal sinuses and allergic inflammation of nasopharyngeal.
Pharmacology Tymazoline is a drug with antihistaminic and sympathomimetic properties. It locally reduces swelling, inflammation and mucosal secretions of the nasal passages.
Toxicity A large overdose or accidental oral intake, especially in children, may cause excessive sedation with drowsiness, reduced body temperature, heart rate relief and fluctuations in blood pressure and collapse.
References
• Levrier J, Molon-Noblot S, Duval D, Lloyd KG: A new ex vivo method for the study of nasal drops on ciliary function. Fundam Clin Pharmacol. 1989;3(5):471-82. [Pubmed]
• Lorino AM, Lofaso F, Drogou I, Abi-Nader F, Dahan E, Coste A, Lorino H: Effects of different mechanical treatments on nasal resistance assessed by rhinometry. Chest. 1998 Jul;114(1):166-70. [Pubmed]
External Links
• Wikipedia

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • Levrier J, Molon-Noblot S, Duval D, Lloyd KG: A new ex vivo method for the study of nasal drops on ciliary function. Fundam Clin Pharmacol. 1989;3(5):471-82. Pubmed
  • • Lorino AM, Lofaso F, Drogou I, Abi-Nader F, Dahan E, Coste A, Lorino H: Effects of different mechanical treatments on nasal resistance assessed by rhinometry. Chest. 1998 Jul;114(1):166-70. Pubmed
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle